ConductScience.org, home

Paper42895897PubMed

Sorting nexin 10 promotes triple-negative breast cancer progression through modulating cholesterol biosynthesis via stabilizing SREBP2.

Guo Y and 8 others. Cancer Biol Ther, 2026.

Cite this record

ConductScience Library. Sorting nexin 10 promotes triple-negative breast cancer progression through modulating cholesterol biosynthesis via stabilizing SREBP2. Papers, record 42895897. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42895897

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Sorting nexin 10 promotes triple-negative breast cancer progression through modulating cholesterol biosynthesis via stabilizing SREBP2.
Journal
Cancer Biol Ther
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-10-22

Source PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Guo YYinping
2Li JJiahui
3Zhang WWenjie
4Xia MMin
5Liu GGaohua
6Zhong XXiaolin
7Yi YYan
8Chen YYajun
9Zhong JJinghttps://orcid.org/0000-0003-4593-4897

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Sorting NexinsMajor topic
Triple Negative Breast NeoplasmsMajor topic
CholesterolMajor topic
Sterol Regulatory Element Binding Protein 2Major topic
Humans
Female
Animals
Mice
Cell Proliferation
Cell Line, Tumor
Disease Progression
Gene Expression Regulation, Neoplastic
Mice, Nude
Cell Movement
Prognosis

Source PubMed

Download CSV of topics

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
141342370Fusion of Tumor Cells with Lipid-Associated Macrophages Drives Metastatic Progression of Breast Cancer.Cancer Res2026https://conductscience.org/library/papers/41342370PubMed
240556739SNX10 in autosomal recessive osteosclerosis, osteosarcoma, rheumatoid arthritis, and osteoporosis: molecular mechanisms and therapeutic implications.Front Cell Dev Biol2025https://conductscience.org/library/papers/40556739PubMed
336038913Recent advances in therapeutic strategies for triple-negative breast cancer.J Hematol Oncol2022https://conductscience.org/library/papers/36038913PubMed
439603572Gentisic acid prevents the development of atherosclerotic lesions by inhibiting SNX10-mediated stabilization of LRP6.Pharmacol Res2024https://conductscience.org/library/papers/39603572PubMed
539775479Cholesterol Metabolism in CNS Diseases: The Potential of SREBP2 and LXR as Therapeutic Targets.Mol Neurobiol2025https://conductscience.org/library/papers/39775479PubMed
632517735Triple-negative breast cancer molecular subtyping and treatment progress.Breast Cancer Res2020https://conductscience.org/library/papers/32517735PubMed
729355659Sorting nexin 10 acts as a tumor suppressor in tumorigenesis and progression of colorectal cancer through regulating chaperone mediated autophagy degradation of p21Cip1/WAF1.Cancer Lett2018https://conductscience.org/library/papers/29355659PubMed
834116656SNX10 and PTGDS are associated with the progression and prognosis of cervical squamous cell carcinoma.BMC Cancer2021https://conductscience.org/library/papers/34116656PubMed
940927753PRMT1-Mediated PARP1 Methylation Drives Lung Metastasis and Chemoresistance via P65 Activation in Triple-Negative Breast Cancer.Research (Wash D C)2025https://conductscience.org/library/papers/40927753PubMed
1040228127SNX10 deficiency impairs sensitivity to anti-HER2 antibody-drug conjugates via altering HER2 trafficking in HER2-positive breast cancer.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40228127PubMed
1139805872Increased SOAT2 expression in aged regulatory T cells is associated with altered cholesterol metabolism and reduced anti-tumor immunity.Nat Commun2025https://conductscience.org/library/papers/39805872PubMed
1239095084SNX10 regulates osteoclastogenic cell fusion and osteoclast size in mice.J Bone Miner Res2024https://conductscience.org/library/papers/39095084PubMed
1333945792Lipid metabolism in cancer: New perspectives and emerging mechanisms.Dev Cell2021https://conductscience.org/library/papers/33945792PubMed
1439367898Inhibiting SNX10 induces autophagy to suppress invasion and EMT and inhibits the PI3K/AKT pathway in cervical cancer.Clin Transl Oncol2025https://conductscience.org/library/papers/39367898PubMed
1530487700Prognostic value of sorting nexin 10 weak expression in stomach adenocarcinoma revealed by weighted gene co-expression network analysis.World J Gastroenterol2018https://conductscience.org/library/papers/30487700PubMed
1637253507Advances in systemic therapies for triple negative breast cancer.BMJ2023https://conductscience.org/library/papers/37253507PubMed
1733241559The molecular structure and function of sorting nexin 10 in skeletal disorders, cancers, and other pathological conditions.J Cell Physiol2021https://conductscience.org/library/papers/33241559PubMed
1831848472Mechanisms and regulation of cholesterol homeostasis.Nat Rev Mol Cell Biol2020https://conductscience.org/library/papers/31848472PubMed
1939817679Cancer statistics, 2025.CA Cancer J Clin2025https://conductscience.org/library/papers/39817679PubMed
2038420162Multi-omics analysis of disulfidptosis regulators and therapeutic potential reveals glycogen synthase 1 as a disulfidptosis triggering target for triple-negative breast cancer.MedComm (2020)2024https://conductscience.org/library/papers/38420162PubMed

See all 42 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42895897

GET https://conductscience.org/api/papers/v1/42895897/references?page=2